Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded Evaluator, Multicenter, Prospective, Between-subjects Clinical Study to Evaluate Safety and Effectiveness of RHA®4 for the Treatment of Midface Volume Deficiency

NCT05133739 is registered in ClinicalTrials.gov with Teoxane SA as lead sponsor.

NCT NCT05133739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded Evaluator, Multicenter, Prospective, Between-subjects Clinical Study to Evaluate Safety and Effectiveness of RHA®4 for the Treatment of Midface Volume Deficiency
Lead sponsor
Teoxane SA
Phase
Not reported
Overall status
Completed
Start date
October 29, 2021
Completion date
January 29, 2024
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cheek augmentation, correction of age-related midface contour deficiencies